2020
DOI: 10.1016/s2214-109x(20)30348-x
|View full text |Cite
|
Sign up to set email alerts
|

The SickleGenAfrica Network

Abstract: forced the network to suspend enrolment. Patients are recruited with broad consent that will allow the sharing of their samples, and clinical, phenotypic, and molecular data with the global scientific community. These resources will serve as a unique reference for future translational studies. Our infrastructure is paving the way for the introduction of new postgraduate programmes in genetics in Africa, including in genetic counselling. Ultimately, SickleGenAfrica will not only tether sickle cell disease to th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…SPARCO will generate a vast amount of data (demographic, clinical, social, laboratory and genomic data) hence the need for capacity in data collection, database management, data analysis and a standardized terminology for SCD in an ontology ( Adekile et al, 2019 ). In addition to SPARCO, other initiatives such as the Sickle Cell Genomics Network of Africa (SickleGenAfrica) and the Consortium for Newborn Screening (NBS) in Africa for Sickle Cell Disease (CONSA) program of the American Hematology Association (Ghana, Liberia, Kenya, Nigeria Tanzania, Uganda, Zambia) will substantially add to the amount of data available on SCD patients in the near future ( Ofori-Acquah, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…SPARCO will generate a vast amount of data (demographic, clinical, social, laboratory and genomic data) hence the need for capacity in data collection, database management, data analysis and a standardized terminology for SCD in an ontology ( Adekile et al, 2019 ). In addition to SPARCO, other initiatives such as the Sickle Cell Genomics Network of Africa (SickleGenAfrica) and the Consortium for Newborn Screening (NBS) in Africa for Sickle Cell Disease (CONSA) program of the American Hematology Association (Ghana, Liberia, Kenya, Nigeria Tanzania, Uganda, Zambia) will substantially add to the amount of data available on SCD patients in the near future ( Ofori-Acquah, 2020 ).…”
Section: Introductionmentioning
confidence: 99%